Deferasirox Tablet
Product Images NDC 73190-052

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 73190-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (052 30)

Deferasirox Tablets film-coated 360 mg per tablet packaging label from AvKARE. The label indicates a package size of 30 tablets for oral administration. It includes storage instructions, dispensing advice, manufacturer details, and a barcode.*

FDA Label Image

Figure (Deferasirox Figure)

A bar chart illustrating the change in liver iron content (mg Fe/g dry weight) and serum ferritin levels (mcg/L) at different doses of Deferasirox (5, 10, 20, 30 mg/kg/day). The x-axis lists Deferasirox doses with sample sizes (n), the left y-axis shows changes in liver iron content, and the right y-axis shows changes in serum ferritin. Liver iron content is represented by white bars, and serum ferritin by black bars, depicting their respective increases or decreases across dosing levels.*

FDA Label Image

Structure (Deferasirox Structure)

Chemical structure diagram of Deferasirox, depicting its molecular rings and functional groups as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.